Puma Biotechnology, Inc. (NASDAQ:PBYI) to Post Q1 2025 Earnings of $0.07 Per Share, Zacks Research Forecasts

Puma Biotechnology, Inc. (NASDAQ:PBYI – Get Rating) – Research analysts at Zacks Research lowered their Q1 2025 earnings per share estimates for shares of Puma Biotechnology in a research note issued to investors on Wednesday, June 7th. Zacks Research analyst K. Shah now anticipates that the biopharmaceutical company will earn $0.07 per share for the […]

Related Keywords

, Nasdaq , Puma Biotechnology Inc , Zacks Research , Affinity Asset Advisors , Cubist Systematic Strategies , Geode Capital Management , Boothbay Fund Management , Puma Biotechnology , Get Rating , Biotechnology Trading Down , Capital Management , Systematic Strategies , Asset Advisors , Sigma Advisers , Fund Management , Puma Biotechnology Daily ,